惠泰医疗: 2025年半年度报告摘要

Company Overview - Shenzhen Huatai Medical Devices Co., Ltd. reported total assets of approximately 3.22 billion RMB, an increase of 8.11% compared to the previous year [1] - The net assets attributable to shareholders reached approximately 2.79 billion RMB, reflecting an 11.05% increase year-on-year [1] Financial Performance - The company's operating revenue for the reporting period was approximately 1.21 billion RMB, representing a year-on-year growth of 21.26% [1] - Total profit amounted to approximately 479.34 million RMB, which is a 23.46% increase compared to the same period last year [1] - The net profit attributable to shareholders was approximately 425.16 million RMB, marking a 24.11% increase year-on-year [1] - The net cash flow from operating activities was approximately 444.65 million RMB, up by 29.45% from the previous year [1] - Basic earnings per share were 3.02 RMB, an increase of 23.27% compared to 2.45 RMB in the previous year [1] - The diluted earnings per share were 3.01 RMB, reflecting a 23.87% increase from 2.43 RMB [1] Shareholder Information - The top shareholder, Shenzhen Mindray Technology Co., Ltd., holds 21.05% of the shares, amounting to approximately 29.69 million shares [2] - The second-largest shareholder, Cheng Zhenghui, owns 18.70% of the shares, equivalent to approximately 26.37 million shares [2] - The total number of shareholders as of the reporting period was 4,507 [1]